

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 8.46583580 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 8.15638580 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.54937301 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.54937301 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.23451050 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.23451050 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.84651165 |
| 8 | oxidative demethylation (GO:0070989) | 6.40556377 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.21694338 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.21694338 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.21694338 |
| 12 | glyoxylate metabolic process (GO:0046487) | 6.06059572 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.99116677 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.96663477 |
| 15 | blood coagulation, intrinsic pathway (GO:0007597) | 5.89466202 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.86224525 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.85441340 |
| 18 | phenylpropanoid metabolic process (GO:0009698) | 5.77106229 |
| 19 | cysteine metabolic process (GO:0006534) | 5.72155247 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.53114280 |
| 21 | urea metabolic process (GO:0019627) | 5.48378896 |
| 22 | urea cycle (GO:0000050) | 5.48378896 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.30486908 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 5.25896839 |
| 25 | regulation of plasminogen activation (GO:0010755) | 5.25481225 |
| 26 | lysine metabolic process (GO:0006553) | 5.19326967 |
| 27 | lysine catabolic process (GO:0006554) | 5.19326967 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.19032005 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 5.17850401 |
| 30 | negative regulation of fibrinolysis (GO:0051918) | 5.15183184 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.05909074 |
| 32 | homocysteine metabolic process (GO:0050667) | 5.04148162 |
| 33 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.00682206 |
| 34 | protein carboxylation (GO:0018214) | 5.00682206 |
| 35 | bile acid metabolic process (GO:0008206) | 4.98679714 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.98092845 |
| 37 | regulation of fibrinolysis (GO:0051917) | 4.94729519 |
| 38 | protein activation cascade (GO:0072376) | 4.94185409 |
| 39 | negative regulation of hemostasis (GO:1900047) | 4.91730789 |
| 40 | negative regulation of blood coagulation (GO:0030195) | 4.91730789 |
| 41 | complement activation, alternative pathway (GO:0006957) | 4.88636984 |
| 42 | ethanol metabolic process (GO:0006067) | 4.87102027 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 4.85675604 |
| 44 | regulation of protein activation cascade (GO:2000257) | 4.84377091 |
| 45 | S-adenosylmethionine metabolic process (GO:0046500) | 4.78774843 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.71091868 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 4.70789627 |
| 48 | alkaloid metabolic process (GO:0009820) | 4.64944066 |
| 49 | complement activation (GO:0006956) | 4.63918708 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 4.60682016 |
| 51 | regulation of triglyceride catabolic process (GO:0010896) | 4.60080013 |
| 52 | regulation of cholesterol esterification (GO:0010872) | 4.57161226 |
| 53 | regulation of complement activation (GO:0030449) | 4.52216745 |
| 54 | reverse cholesterol transport (GO:0043691) | 4.51951981 |
| 55 | complement activation, classical pathway (GO:0006958) | 4.51826043 |
| 56 | hormone catabolic process (GO:0042447) | 4.51540219 |
| 57 | drug catabolic process (GO:0042737) | 4.50789874 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 4.48941393 |
| 59 | negative regulation of sterol transport (GO:0032372) | 4.48941393 |
| 60 | negative regulation of coagulation (GO:0050819) | 4.47334614 |
| 61 | protein-lipid complex remodeling (GO:0034368) | 4.45753951 |
| 62 | macromolecular complex remodeling (GO:0034367) | 4.45753951 |
| 63 | plasma lipoprotein particle remodeling (GO:0034369) | 4.45753951 |
| 64 | acylglycerol homeostasis (GO:0055090) | 4.42173680 |
| 65 | triglyceride homeostasis (GO:0070328) | 4.42173680 |
| 66 | negative regulation of wound healing (GO:0061045) | 4.42026917 |
| 67 | indolalkylamine metabolic process (GO:0006586) | 4.40849791 |
| 68 | serine family amino acid metabolic process (GO:0009069) | 4.38472420 |
| 69 | acute-phase response (GO:0006953) | 4.38079806 |
| 70 | cellular amino acid catabolic process (GO:0009063) | 4.37344001 |
| 71 | glutamate metabolic process (GO:0006536) | 4.35802023 |
| 72 | glycine metabolic process (GO:0006544) | 4.33677229 |
| 73 | regulation of humoral immune response (GO:0002920) | 4.32527744 |
| 74 | cellular glucuronidation (GO:0052695) | 4.30178497 |
| 75 | amine catabolic process (GO:0009310) | 4.28395644 |
| 76 | cellular biogenic amine catabolic process (GO:0042402) | 4.28395644 |
| 77 | drug transmembrane transport (GO:0006855) | 4.27985571 |
| 78 | coenzyme catabolic process (GO:0009109) | 4.27981476 |
| 79 | phospholipid efflux (GO:0033700) | 4.27671761 |
| 80 | cellular modified amino acid catabolic process (GO:0042219) | 4.26748943 |
| 81 | urate metabolic process (GO:0046415) | 4.26530152 |
| 82 | positive regulation of blood coagulation (GO:0030194) | 4.25590938 |
| 83 | positive regulation of hemostasis (GO:1900048) | 4.25590938 |
| 84 | negative regulation of protein activation cascade (GO:2000258) | 4.25493518 |
| 85 | bile acid and bile salt transport (GO:0015721) | 4.23729391 |
| 86 | benzene-containing compound metabolic process (GO:0042537) | 4.20027110 |
| 87 | serine family amino acid biosynthetic process (GO:0009070) | 4.13925814 |
| 88 | opsonization (GO:0008228) | 4.13281060 |
| 89 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.10615670 |
| 90 | plasma lipoprotein particle clearance (GO:0034381) | 4.09524665 |
| 91 | heme transport (GO:0015886) | 4.08473566 |
| 92 | imidazole-containing compound metabolic process (GO:0052803) | 4.07870977 |
| 93 | negative regulation of lipase activity (GO:0060192) | 4.07572196 |
| 94 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.04064703 |
| 95 | ethanol oxidation (GO:0006069) | 4.03073455 |
| 96 | aldehyde catabolic process (GO:0046185) | 4.01965908 |
| 97 | exogenous drug catabolic process (GO:0042738) | 3.99375065 |
| 98 | short-chain fatty acid metabolic process (GO:0046459) | 3.99036966 |
| 99 | ketone body metabolic process (GO:1902224) | 3.98660174 |
| 100 | cholesterol efflux (GO:0033344) | 3.96530581 |
| 101 | positive regulation of coagulation (GO:0050820) | 3.91984325 |
| 102 | arginine metabolic process (GO:0006525) | 3.91848765 |
| 103 | polyketide metabolic process (GO:0030638) | 3.91182675 |
| 104 | doxorubicin metabolic process (GO:0044598) | 3.91182675 |
| 105 | daunorubicin metabolic process (GO:0044597) | 3.91182675 |
| 106 | cytolysis (GO:0019835) | 3.90694500 |
| 107 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.88859993 |
| 108 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.88859993 |
| 109 | uronic acid metabolic process (GO:0006063) | 3.88339241 |
| 110 | glucuronate metabolic process (GO:0019585) | 3.88339241 |
| 111 | intestinal cholesterol absorption (GO:0030299) | 3.86555680 |
| 112 | carboxylic acid catabolic process (GO:0046395) | 3.86481093 |
| 113 | organic acid catabolic process (GO:0016054) | 3.86481093 |
| 114 | aspartate family amino acid catabolic process (GO:0009068) | 3.80154845 |
| 115 | regulation of bile acid biosynthetic process (GO:0070857) | 3.77687717 |
| 116 | plasma lipoprotein particle assembly (GO:0034377) | 3.77160850 |
| 117 | regulation of lipoprotein particle clearance (GO:0010984) | 3.76758232 |
| 118 | low-density lipoprotein particle remodeling (GO:0034374) | 3.72516513 |
| 119 | fibrinolysis (GO:0042730) | 3.72307401 |
| 120 | regulation of cholesterol homeostasis (GO:2000188) | 3.70823149 |
| 121 | response to mercury ion (GO:0046689) | 3.70566363 |
| 122 | cholesterol homeostasis (GO:0042632) | 3.66894266 |
| 123 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.65468178 |
| 124 | 2-oxoglutarate metabolic process (GO:0006103) | 3.65071127 |
| 125 | flavonoid metabolic process (GO:0009812) | 3.64686200 |
| 126 | phospholipid homeostasis (GO:0055091) | 3.64477491 |
| 127 | cofactor catabolic process (GO:0051187) | 3.63041488 |
| 128 | carnitine metabolic process (GO:0009437) | 3.62779305 |
| 129 | sterol homeostasis (GO:0055092) | 3.62633056 |
| 130 | fatty acid beta-oxidation (GO:0006635) | 3.61843887 |
| 131 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.61831308 |
| 132 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.61831308 |
| 133 | positive regulation of lipid catabolic process (GO:0050996) | 3.61580836 |
| 134 | fatty acid oxidation (GO:0019395) | 3.61150123 |
| 135 | drug metabolic process (GO:0017144) | 3.61067845 |
| 136 | monocarboxylic acid catabolic process (GO:0072329) | 3.60800673 |
| 137 | xenobiotic metabolic process (GO:0006805) | 3.59261297 |
| 138 | steroid catabolic process (GO:0006706) | 3.58262190 |
| 139 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.56977126 |
| 140 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.55489706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.34388486 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.13875424 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.76663838 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.47216083 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.16707699 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.84454978 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.83397863 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.00189670 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.85911918 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.12168274 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.11941074 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08268161 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7397980 |
| 14 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62887551 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60755780 |
| 16 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.46927323 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.40019880 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36056209 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25204710 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17135991 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17007130 |
| 22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15143185 |
| 23 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07682070 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06214124 |
| 25 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03319874 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03312334 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01404968 |
| 28 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.00459648 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99676312 |
| 30 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.98955735 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95731394 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94646879 |
| 33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.93731948 |
| 34 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.93021493 |
| 35 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.92948024 |
| 36 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91806171 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.91411077 |
| 38 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.86936285 |
| 39 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.86462216 |
| 40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86239172 |
| 41 | NFYA_21822215_ChIP-Seq_K562_Human | 0.84769889 |
| 42 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84320139 |
| 43 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81373330 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.80613996 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80203420 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79815845 |
| 47 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.79183831 |
| 48 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77077786 |
| 49 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.76726703 |
| 50 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.76233339 |
| 51 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.74842053 |
| 52 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74707993 |
| 53 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73359497 |
| 54 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.72748385 |
| 55 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72438262 |
| 56 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.71639037 |
| 57 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71009229 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70305676 |
| 59 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.70296776 |
| 60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.70294821 |
| 61 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70109002 |
| 62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.69931489 |
| 63 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69754669 |
| 64 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68963874 |
| 65 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66609354 |
| 66 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66609354 |
| 67 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.66564369 |
| 68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66257297 |
| 69 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.66140850 |
| 70 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.65797534 |
| 71 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.64451866 |
| 72 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63523829 |
| 73 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.63430708 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62726431 |
| 75 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61969472 |
| 76 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61893071 |
| 77 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.61737062 |
| 78 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.61568845 |
| 79 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.61229915 |
| 80 | NFYB_21822215_ChIP-Seq_K562_Human | 0.60572270 |
| 81 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60156153 |
| 82 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.58928611 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.58874967 |
| 84 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.58085227 |
| 85 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58007326 |
| 86 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.56670485 |
| 87 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55962231 |
| 88 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.55601757 |
| 89 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.55420193 |
| 90 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54872066 |
| 91 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.54272975 |
| 92 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54079803 |
| 93 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.53850251 |
| 94 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53032494 |
| 95 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.52113017 |
| 96 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52027257 |
| 97 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.51732828 |
| 98 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51721225 |
| 99 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.51391916 |
| 100 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.51318412 |
| 101 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51002233 |
| 102 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.49966566 |
| 103 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.49693318 |
| 104 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.49163333 |
| 105 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.49153774 |
| 106 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.49016898 |
| 107 | NCOR_22424771_ChIP-Seq_293T_Human | 0.48714475 |
| 108 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.48676505 |
| 109 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.48368892 |
| 110 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.48368892 |
| 111 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.47760428 |
| 112 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47389734 |
| 113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45556778 |
| 114 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45357935 |
| 115 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44494197 |
| 116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44158566 |
| 117 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44061025 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.44007167 |
| 119 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.43696431 |
| 120 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.41857469 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41734052 |
| 122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41724796 |
| 123 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41543681 |
| 124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.40868821 |
| 125 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.40602827 |
| 126 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.40359688 |
| 127 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.40030684 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39784071 |
| 129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39592484 |
| 130 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.39336827 |
| 131 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.39297740 |
| 132 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39118880 |
| 133 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.38284168 |
| 134 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.38129399 |
| 135 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37512840 |
| 136 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.37336207 |
| 137 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.37009907 |
| 138 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.36745830 |
| 139 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36744651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.29343064 |
| 2 | MP0005360_urolithiasis | 7.88043656 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.27100632 |
| 4 | MP0005365_abnormal_bile_salt | 6.00598523 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.16795549 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.03324571 |
| 7 | MP0003252_abnormal_bile_duct | 4.00629013 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.39463985 |
| 9 | MP0005332_abnormal_amino_acid | 3.09277529 |
| 10 | MP0009840_abnormal_foam_cell | 3.03072846 |
| 11 | MP0003195_calcinosis | 3.00505646 |
| 12 | MP0005083_abnormal_biliary_tract | 2.81887172 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.60935402 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.55539520 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.31350111 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.16452503 |
| 17 | MP0000609_abnormal_liver_physiology | 2.07467811 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.04903193 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.84065860 |
| 20 | MP0003868_abnormal_feces_composition | 1.77765282 |
| 21 | MP0001764_abnormal_homeostasis | 1.65852024 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.62141844 |
| 23 | MP0005451_abnormal_body_composition | 1.59196889 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.56642655 |
| 25 | MP0009697_abnormal_copulation | 1.38673264 |
| 26 | MP0003186_abnormal_redox_activity | 1.34913092 |
| 27 | MP0003011_delayed_dark_adaptation | 1.21853709 |
| 28 | MP0005636_abnormal_mineral_homeostasis | 1.17723729 |
| 29 | MP0000598_abnormal_liver_morphology | 1.14090187 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.11473767 |
| 31 | MP0002132_abnormal_respiratory_system | 1.07649508 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.05065419 |
| 33 | MP0009764_decreased_sensitivity_to | 1.04927192 |
| 34 | MP0005647_abnormal_sex_gland | 1.02865783 |
| 35 | MP0000604_amyloidosis | 0.97649260 |
| 36 | MP0009763_increased_sensitivity_to | 0.92856463 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 0.91394332 |
| 38 | MP0002254_reproductive_system_inflammat | 0.90184324 |
| 39 | MP0005670_abnormal_white_adipose | 0.89162553 |
| 40 | MP0005187_abnormal_penis_morphology | 0.88421293 |
| 41 | MP0001756_abnormal_urination | 0.88163894 |
| 42 | MP0009642_abnormal_blood_homeostasis | 0.88077647 |
| 43 | MP0002876_abnormal_thyroid_physiology | 0.88059545 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 0.87955199 |
| 45 | MP0001915_intracranial_hemorrhage | 0.86582996 |
| 46 | MP0008469_abnormal_protein_level | 0.86385926 |
| 47 | MP0004043_abnormal_pH_regulation | 0.83428064 |
| 48 | MP0005408_hypopigmentation | 0.81058444 |
| 49 | MP0005376_homeostasis/metabolism_phenot | 0.76813682 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 0.76663616 |
| 51 | MP0010368_abnormal_lymphatic_system | 0.76204094 |
| 52 | MP0009765_abnormal_xenobiotic_induced | 0.75657108 |
| 53 | MP0002136_abnormal_kidney_physiology | 0.74651371 |
| 54 | MP0005535_abnormal_body_temperature | 0.72500010 |
| 55 | MP0005220_abnormal_exocrine_pancreas | 0.71818296 |
| 56 | MP0002282_abnormal_trachea_morphology | 0.71225196 |
| 57 | MP0001661_extended_life_span | 0.69508687 |
| 58 | MP0002971_abnormal_brown_adipose | 0.69101531 |
| 59 | MP0005334_abnormal_fat_pad | 0.64855122 |
| 60 | MP0005266_abnormal_metabolism | 0.63385056 |
| 61 | MP0003879_abnormal_hair_cell | 0.63252788 |
| 62 | MP0004130_abnormal_muscle_cell | 0.63051343 |
| 63 | MP0003329_amyloid_beta_deposits | 0.60337906 |
| 64 | MP0003690_abnormal_glial_cell | 0.60011784 |
| 65 | MP0009053_abnormal_anal_canal | 0.59919734 |
| 66 | MP0006035_abnormal_mitochondrial_morpho | 0.59656765 |
| 67 | MP0002928_abnormal_bile_duct | 0.58855277 |
| 68 | MP0001765_abnormal_ion_homeostasis | 0.54882554 |
| 69 | MP0003638_abnormal_response/metabolism_ | 0.52577801 |
| 70 | MP0002249_abnormal_larynx_morphology | 0.51251741 |
| 71 | MP0005395_other_phenotype | 0.50822302 |
| 72 | MP0005448_abnormal_energy_balance | 0.50184690 |
| 73 | MP0000639_abnormal_adrenal_gland | 0.48711013 |
| 74 | MP0005023_abnormal_wound_healing | 0.48579294 |
| 75 | MP0005666_abnormal_adipose_tissue | 0.46659585 |
| 76 | MP0000230_abnormal_systemic_arterial | 0.44023166 |
| 77 | MP0008874_decreased_physiological_sensi | 0.43659353 |
| 78 | MP0005464_abnormal_platelet_physiology | 0.42564360 |
| 79 | MP0003953_abnormal_hormone_level | 0.42242655 |
| 80 | MP0005058_abnormal_lysosome_morphology | 0.41697079 |
| 81 | MP0002822_catalepsy | 0.41635673 |
| 82 | MP0002168_other_aberrant_phenotype | 0.41405512 |
| 83 | MP0008873_increased_physiological_sensi | 0.40991467 |
| 84 | MP0003718_maternal_effect | 0.40156529 |
| 85 | MP0003724_increased_susceptibility_to | 0.39313063 |
| 86 | MP0003959_abnormal_lean_body | 0.39223812 |
| 87 | MP0008872_abnormal_physiological_respon | 0.38139754 |
| 88 | MP0009785_altered_susceptibility_to | 0.38116600 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.37209808 |
| 90 | MP0002796_impaired_skin_barrier | 0.36951363 |
| 91 | MP0009672_abnormal_birth_weight | 0.36394830 |
| 92 | MP0003075_altered_response_to | 0.36206912 |
| 93 | MP0005166_decreased_susceptibility_to | 0.35937164 |
| 94 | MP0002837_dystrophic_cardiac_calcinosis | 0.35701264 |
| 95 | MP0002332_abnormal_exercise_endurance | 0.34067046 |
| 96 | MP0003436_decreased_susceptibility_to | 0.31627272 |
| 97 | MP0009115_abnormal_fat_cell | 0.31463913 |
| 98 | MP0004883_abnormal_blood_vessel | 0.31398591 |
| 99 | MP0005164_abnormal_response_to | 0.31073233 |
| 100 | MP0005248_abnormal_Harderian_gland | 0.30909228 |
| 101 | MP0002135_abnormal_kidney_morphology | 0.30780080 |
| 102 | MP0000538_abnormal_urinary_bladder | 0.30664403 |
| 103 | MP0005197_abnormal_uvea_morphology | 0.30481836 |
| 104 | MP0009384_cardiac_valve_regurgitation | 0.30393183 |
| 105 | MP0000467_abnormal_esophagus_morphology | 0.30244277 |
| 106 | MP0004264_abnormal_extraembryonic_tissu | 0.29424678 |
| 107 | MP0006082_CNS_inflammation | 0.28617507 |
| 108 | MP0003300_gastrointestinal_ulcer | 0.28166239 |
| 109 | MP0000579_abnormal_nail_morphology | 0.27598204 |
| 110 | MP0001845_abnormal_inflammatory_respons | 0.27165573 |
| 111 | MP0004381_abnormal_hair_follicle | 0.26492705 |
| 112 | MP0000249_abnormal_blood_vessel | 0.26400179 |
| 113 | MP0002970_abnormal_white_adipose | 0.26334881 |
| 114 | MP0001853_heart_inflammation | 0.25239198 |
| 115 | MP0004142_abnormal_muscle_tone | 0.19930555 |
| 116 | MP0001851_eye_inflammation | 0.19508406 |
| 117 | MP0000566_synostosis | 0.19299399 |
| 118 | MP0001881_abnormal_mammary_gland | 0.18776472 |
| 119 | MP0002128_abnormal_blood_circulation | 0.17681039 |
| 120 | MP0004272_abnormal_basement_membrane | 0.15693214 |
| 121 | MP0003633_abnormal_nervous_system | 0.13174803 |
| 122 | MP0003632_abnormal_nervous_system | 0.11262027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.14576937 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.98614198 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.77980749 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.37497864 |
| 5 | Xanthomatosis (HP:0000991) | 6.10588129 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.04174961 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.91455655 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.12767825 |
| 9 | Complement deficiency (HP:0004431) | 4.74815127 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.68527863 |
| 11 | Hyperammonemia (HP:0001987) | 4.67138764 |
| 12 | Hyperglycinemia (HP:0002154) | 4.49418840 |
| 13 | Ketosis (HP:0001946) | 4.49412512 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.47603270 |
| 15 | Joint hemorrhage (HP:0005261) | 4.42079625 |
| 16 | Hyperglycinuria (HP:0003108) | 4.41701881 |
| 17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.36464594 |
| 18 | Epidermoid cyst (HP:0200040) | 4.32985817 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.30919162 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.25912198 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 4.25912198 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.08905888 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 4.08368344 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 4.02826064 |
| 25 | Fat malabsorption (HP:0002630) | 3.99002900 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.86171431 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.77623289 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.74236042 |
| 29 | Nephritis (HP:0000123) | 3.71596428 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.63712780 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.58718777 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.43618725 |
| 33 | Abnormality of complement system (HP:0005339) | 3.42442768 |
| 34 | Abnormality of nucleobase metabolism (HP:0010932) | 3.40857568 |
| 35 | Abnormality of the intrinsic pathway (HP:0010989) | 3.40719137 |
| 36 | Ketoacidosis (HP:0001993) | 3.39779479 |
| 37 | Gout (HP:0001997) | 3.39081179 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33118093 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.31332398 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.25666525 |
| 41 | Abnormality of purine metabolism (HP:0004352) | 3.24168331 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.11575934 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.97976174 |
| 44 | Metabolic acidosis (HP:0001942) | 2.96768711 |
| 45 | Steatorrhea (HP:0002570) | 2.93379761 |
| 46 | Reduced antithrombin III activity (HP:0001976) | 2.85658464 |
| 47 | Vascular calcification (HP:0004934) | 2.83667242 |
| 48 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.78399464 |
| 49 | Dicarboxylic aciduria (HP:0003215) | 2.78399464 |
| 50 | Osteomalacia (HP:0002749) | 2.77903022 |
| 51 | Lethargy (HP:0001254) | 2.73924268 |
| 52 | Myocardial infarction (HP:0001658) | 2.68133954 |
| 53 | Fair hair (HP:0002286) | 2.64982418 |
| 54 | Skin nodule (HP:0200036) | 2.63479166 |
| 55 | Spontaneous abortion (HP:0005268) | 2.62274585 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.58610206 |
| 57 | Generalized aminoaciduria (HP:0002909) | 2.56870605 |
| 58 | Neonatal hypoglycemia (HP:0001998) | 2.56254207 |
| 59 | Malnutrition (HP:0004395) | 2.55700158 |
| 60 | Spastic diplegia (HP:0001264) | 2.51562892 |
| 61 | Cardiovascular calcification (HP:0011915) | 2.51349392 |
| 62 | Proximal tubulopathy (HP:0000114) | 2.50387253 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.49550701 |
| 64 | Irritability (HP:0000737) | 2.46332519 |
| 65 | Acanthocytosis (HP:0001927) | 2.45997493 |
| 66 | Alkalosis (HP:0001948) | 2.45966753 |
| 67 | Cerebral edema (HP:0002181) | 2.42779933 |
| 68 | Pulmonary embolism (HP:0002204) | 2.41365098 |
| 69 | Purpura (HP:0000979) | 2.41155173 |
| 70 | Neonatal onset (HP:0003623) | 2.40829354 |
| 71 | Increased purine levels (HP:0004368) | 2.36881220 |
| 72 | Hyperuricemia (HP:0002149) | 2.36881220 |
| 73 | Enlarged kidneys (HP:0000105) | 2.33913975 |
| 74 | Hypoglycemic seizures (HP:0002173) | 2.33463365 |
| 75 | Abnormal gallbladder morphology (HP:0012437) | 2.29775074 |
| 76 | Sensorimotor neuropathy (HP:0007141) | 2.29328407 |
| 77 | Hydroxyprolinuria (HP:0003080) | 2.27582877 |
| 78 | Abnormality of proline metabolism (HP:0010907) | 2.27582877 |
| 79 | Vomiting (HP:0002013) | 2.27506483 |
| 80 | Mitral stenosis (HP:0001718) | 2.25343696 |
| 81 | Cholelithiasis (HP:0001081) | 2.24859622 |
| 82 | Cholecystitis (HP:0001082) | 2.24733132 |
| 83 | Abnormal gallbladder physiology (HP:0012438) | 2.24733132 |
| 84 | Hyperphosphaturia (HP:0003109) | 2.24228180 |
| 85 | Rickets (HP:0002748) | 2.23348871 |
| 86 | Late onset (HP:0003584) | 2.21280701 |
| 87 | Glycosuria (HP:0003076) | 2.19807286 |
| 88 | Abnormality of urine glucose concentration (HP:0011016) | 2.19807286 |
| 89 | Glomerulonephritis (HP:0000099) | 2.19595692 |
| 90 | Pancreatitis (HP:0001733) | 2.17766636 |
| 91 | Esophageal varix (HP:0002040) | 2.10515386 |
| 92 | Elevated alkaline phosphatase (HP:0003155) | 2.09881081 |
| 93 | Brushfield spots (HP:0001088) | 2.05029843 |
| 94 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.03677804 |
| 95 | Amyloidosis (HP:0011034) | 1.99542149 |
| 96 | Opisthotonus (HP:0002179) | 1.98787501 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97528014 |
| 98 | Menorrhagia (HP:0000132) | 1.95254912 |
| 99 | Bile duct proliferation (HP:0001408) | 1.95180130 |
| 100 | Abnormal biliary tract physiology (HP:0012439) | 1.95180130 |
| 101 | Hypophosphatemic rickets (HP:0004912) | 1.93152493 |
| 102 | Thrombophlebitis (HP:0004418) | 1.92477127 |
| 103 | Abnormality of the gallbladder (HP:0005264) | 1.91307732 |
| 104 | Abnormal cartilage morphology (HP:0002763) | 1.89896278 |
| 105 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.89274380 |
| 106 | Poikilocytosis (HP:0004447) | 1.88560856 |
| 107 | Arthropathy (HP:0003040) | 1.88289346 |
| 108 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.88179787 |
| 109 | Bifid scrotum (HP:0000048) | 1.87281572 |
| 110 | Renal cortical cysts (HP:0000803) | 1.86534024 |
| 111 | Gingival bleeding (HP:0000225) | 1.86334573 |
| 112 | Hemorrhage of the eye (HP:0011885) | 1.84924522 |
| 113 | Increased mean platelet volume (HP:0011877) | 1.84578361 |
| 114 | Confusion (HP:0001289) | 1.84029682 |
| 115 | Generalized hypopigmentation of hair (HP:0011358) | 1.82937041 |
| 116 | Abnormality of vitamin metabolism (HP:0100508) | 1.81332894 |
| 117 | Gangrene (HP:0100758) | 1.78785582 |
| 118 | Abnormal urine phosphate concentration (HP:0012599) | 1.78520411 |
| 119 | Atrioventricular block (HP:0001678) | 1.76164738 |
| 120 | Abnormality of the Achilles tendon (HP:0005109) | 1.75723111 |
| 121 | Abnormality of iron homeostasis (HP:0011031) | 1.71182514 |
| 122 | Joint swelling (HP:0001386) | 1.70760187 |
| 123 | Increased serum ferritin (HP:0003281) | 1.66389746 |
| 124 | Abnormal platelet volume (HP:0011876) | 1.65891794 |
| 125 | Reticulocytosis (HP:0001923) | 1.59705959 |
| 126 | Cerebral palsy (HP:0100021) | 1.58269017 |
| 127 | Blue irides (HP:0000635) | 1.55013191 |
| 128 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.54861960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.23908020 |
| 2 | FGFR4 | 4.30554708 |
| 3 | SIK1 | 4.12240756 |
| 4 | ERN1 | 3.94345032 |
| 5 | INSRR | 2.92978947 |
| 6 | ERBB4 | 2.71770224 |
| 7 | TAOK3 | 2.65781180 |
| 8 | MST1R | 2.40146371 |
| 9 | MAP2K4 | 2.20990348 |
| 10 | PKN2 | 2.05327086 |
| 11 | MAP3K12 | 2.00976124 |
| 12 | MAPK11 | 1.86596277 |
| 13 | WNK4 | 1.81749022 |
| 14 | PIK3CA | 1.77395786 |
| 15 | WNK3 | 1.75510633 |
| 16 | PIK3CG | 1.73236867 |
| 17 | FLT3 | 1.67929611 |
| 18 | LATS1 | 1.67158436 |
| 19 | NTRK3 | 1.66304011 |
| 20 | TRIB3 | 1.57468927 |
| 21 | FRK | 1.56557364 |
| 22 | PRPF4B | 1.55617463 |
| 23 | STK38L | 1.53225224 |
| 24 | TYK2 | 1.50530151 |
| 25 | ABL2 | 1.49540077 |
| 26 | MYLK | 1.47375285 |
| 27 | PTK6 | 1.45120372 |
| 28 | OXSR1 | 1.40629343 |
| 29 | DAPK2 | 1.32620340 |
| 30 | MAP3K7 | 1.32150992 |
| 31 | NEK9 | 1.32016833 |
| 32 | PINK1 | 1.29828042 |
| 33 | GRK6 | 1.23801100 |
| 34 | ARAF | 1.23713406 |
| 35 | FGFR2 | 1.23000354 |
| 36 | TNK2 | 1.19557450 |
| 37 | KDR | 1.16893337 |
| 38 | PRKAA2 | 1.16680081 |
| 39 | JAK2 | 1.12066249 |
| 40 | MAP3K3 | 1.04796037 |
| 41 | MAP3K10 | 1.04175285 |
| 42 | MAP2K3 | 1.02345590 |
| 43 | MAP3K14 | 1.00763506 |
| 44 | FER | 0.99431958 |
| 45 | CASK | 0.95324030 |
| 46 | PRKCZ | 0.93151451 |
| 47 | ERBB2 | 0.92859065 |
| 48 | MUSK | 0.92441344 |
| 49 | EPHB1 | 0.92106183 |
| 50 | MAPK4 | 0.91909794 |
| 51 | MAP3K1 | 0.91907996 |
| 52 | TBK1 | 0.91410695 |
| 53 | EIF2AK1 | 0.90521066 |
| 54 | SCYL2 | 0.89144107 |
| 55 | MET | 0.89076289 |
| 56 | PRKACA | 0.88910613 |
| 57 | KSR2 | 0.87543314 |
| 58 | JAK1 | 0.87523346 |
| 59 | MAP3K2 | 0.87222460 |
| 60 | SGK3 | 0.86987285 |
| 61 | NLK | 0.85174323 |
| 62 | PRKG1 | 0.83588047 |
| 63 | PDK4 | 0.82620720 |
| 64 | PDK3 | 0.82620720 |
| 65 | MAP3K9 | 0.82270377 |
| 66 | GSK3A | 0.80734962 |
| 67 | TIE1 | 0.80575087 |
| 68 | MAPK15 | 0.79076208 |
| 69 | DYRK1B | 0.78093513 |
| 70 | SGK494 | 0.76775084 |
| 71 | SGK223 | 0.76775084 |
| 72 | PRKAA1 | 0.75497921 |
| 73 | CSNK1D | 0.75292292 |
| 74 | PRKACG | 0.73765386 |
| 75 | MAPK12 | 0.72818423 |
| 76 | BCR | 0.72108301 |
| 77 | SGK2 | 0.68993535 |
| 78 | MAP3K11 | 0.68688714 |
| 79 | CDK6 | 0.68208140 |
| 80 | MAP2K6 | 0.66497446 |
| 81 | PTK2 | 0.64567105 |
| 82 | CSK | 0.64207446 |
| 83 | RIPK1 | 0.64151508 |
| 84 | IRAK3 | 0.64121481 |
| 85 | CAMKK2 | 0.61608293 |
| 86 | CAMK2G | 0.61480809 |
| 87 | TGFBR2 | 0.59464580 |
| 88 | PDPK1 | 0.58897803 |
| 89 | PRKCB | 0.55076022 |
| 90 | RPS6KA3 | 0.54834551 |
| 91 | EPHA3 | 0.54271453 |
| 92 | CAMK1D | 0.53310839 |
| 93 | PRKACB | 0.50417859 |
| 94 | EPHA4 | 0.49374551 |
| 95 | PRKCQ | 0.48467648 |
| 96 | FGFR3 | 0.48102132 |
| 97 | MAPK7 | 0.48092774 |
| 98 | CAMKK1 | 0.46274758 |
| 99 | CSNK1G1 | 0.44202352 |
| 100 | CSF1R | 0.43119799 |
| 101 | NEK1 | 0.42406920 |
| 102 | MAP3K5 | 0.41622514 |
| 103 | IGF1R | 0.40862762 |
| 104 | SGK1 | 0.40643302 |
| 105 | IKBKE | 0.40173530 |
| 106 | SRC | 0.39733833 |
| 107 | CSNK1E | 0.39488086 |
| 108 | PDK2 | 0.39247406 |
| 109 | GRK1 | 0.38621202 |
| 110 | PDK1 | 0.38197581 |
| 111 | MAP3K6 | 0.37029795 |
| 112 | STK39 | 0.36196839 |
| 113 | MAP2K1 | 0.35950188 |
| 114 | PRKCG | 0.35506980 |
| 115 | STK38 | 0.35096271 |
| 116 | CSNK2A1 | 0.33858432 |
| 117 | MAP3K13 | 0.33769707 |
| 118 | RET | 0.33318665 |
| 119 | MTOR | 0.32791441 |
| 120 | ICK | 0.32161707 |
| 121 | TAOK2 | 0.31370405 |
| 122 | CDK4 | 0.31149378 |
| 123 | IRAK2 | 0.30933432 |
| 124 | RAF1 | 0.30759753 |
| 125 | AKT3 | 0.29859378 |
| 126 | EGFR | 0.28797827 |
| 127 | ZAP70 | 0.28117906 |
| 128 | PRKCA | 0.27597686 |
| 129 | PAK3 | 0.26506948 |
| 130 | PBK | 0.26191038 |
| 131 | CAMK4 | 0.25789841 |
| 132 | PKN1 | 0.25714276 |
| 133 | IRAK1 | 0.25393551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.28740525 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.46368524 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.41171014 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.31114812 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.94527441 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71730277 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.70571071 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69520443 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56308850 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52056620 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51016369 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.45980273 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.40136256 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.38572012 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.18921128 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.08850944 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06728729 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88132377 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87421051 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.86381307 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85994963 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85426201 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83210088 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.82481189 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.79772032 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71724669 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.70760714 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.69773272 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.64719661 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64662087 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64023167 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.56881451 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56455107 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52560310 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51723005 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.41400684 |
| 37 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35188649 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34825527 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33996588 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33662344 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31099310 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28954529 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.28317303 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22201682 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20134346 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19764653 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.16195979 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.15498034 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14235642 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13502701 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.10918341 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.06364795 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03826894 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98665732 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91976787 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.89714506 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86743583 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84843452 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80612831 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76549228 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75772692 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73983993 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68906503 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66571121 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58845006 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47953714 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44931291 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34386327 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31875075 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28449257 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.26962488 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24875443 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.22898143 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.22212346 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21373131 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19697220 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16298281 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13178528 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09214519 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02132335 |
| 81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.00902859 |
| 82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2682509 |
| 83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2545848 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2398136 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2368383 |
| 86 | Lysosome_Homo sapiens_hsa04142 | -0.2294307 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2294118 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2273513 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2208550 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2071070 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2045842 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1926032 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1790170 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1757732 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1354035 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1327316 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1286269 |
| 98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1270423 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1209979 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | -0.1110623 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1089443 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0973498 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0939184 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0918749 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0833965 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0565235 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | -0.0500147 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0385714 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0286156 |

